Zanovex

Zanovex is a Singapore-based pharmaceutical company and a wholly-owned subsidiary of Zuellig Pharma, a leading healthcare services provider in Asia. The company functions as a strategic entity for the acquisition and management of established pharmaceutical brands within the ASEAN region. In February 2024, Zanovex completed the acquisition of the oncology drug Alimta (pemetrexed) and the men's health product Cialis (tadalafil) from Eli Lilly for eight Southeast Asian markets. Zanovex holds the trademarks, marketing authorizations, and manufacturing licenses for these products, while commercial activities are executed by ZP Therapeutics. The company's portfolio focuses on critical therapeutic areas including oncology and urology.